US Broker Ratings

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 62% Upside Potential as Biotech Innovates in Hematology

Disc Medicine, Inc. (NASDAQ: IRON) is garnering significant attention within the biotechnology sector, particularly amongst investors focused on innovative healthcare solutions. As a clinical-stage biopharmaceutical company,..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Uncovering a 22% Upside with Strong Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to treating hemolytic anemias and a promising pipeline of therapies...

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth in the Medical Device Sector

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, is garnering attention from investors with its dynamic growth trajectory..

Evotec SE (EVO) Stock Analysis: Unlocking a Potential 61% Upside Amidst Strategic Collaborations

For investors seeking opportunities in the healthcare sector, Evotec SE (NASDAQ: EVO), a prominent player in the drug discovery and development industry, presents an intriguing proposition...

Denali Therapeutics Inc. (DNLI) Investor Outlook: Unpacking the 136% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a biotechnology firm entrenched in the healthcare sector, has caught the attention of investors with its ambitious pipeline and substantial potential..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 220% Potential Upside

Investors seeking opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). This San Diego-based biopharmaceutical firm is..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unveiling a 36.62% Potential Upside with Innovative Biotech Solutions

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning player in the healthcare sector, is capturing significant investor attention due to its promising portfolio of therapeutic candidates targeting..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a Potential 163% Upside in the Biotechnology Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a biotechnology firm based in Waltham, Massachusetts, has captured investor attention with its promising potential upside of 163.04%. As a clinical-stage..

Premier, Inc. (PINC) Stock Analysis: Evaluating the Healthcare Leader Amidst Revenue Decline

As the healthcare sector continues to evolve, Premier, Inc. (NASDAQ: PINC) stands out as a key player in health information services. Headquartered in Charlotte, North Carolina,..

PROCEPT BioRobotics (PRCT) Investor Outlook: Navigating a 70% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative surgical robotics solutions. As a key player in the medical devices..

Mesoblast Limited (MESO): Investor Outlook Highlights 60% Potential Upside

For investors with an eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) offers an intriguing opportunity. The Australian-based company is making waves with its regenerative..

Progyny, Inc. (PGNY) Stock Report: 27.65% Potential Upside Captures Investor Attention

Progyny, Inc. (NASDAQ: PGNY) is gaining traction in the healthcare sector with its innovative approach to fertility and family-building benefits. As a leader in healthcare plans,..

Select Medical Holdings Corpora (SEM): Investor Outlook on a 36.81% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Astrana Health Inc. (ASTH): Investor Outlook Highlights 66% Potential Upside

Astrana Health Inc. (ASTH), a healthcare management company headquartered in Alhambra, California, is attracting significant investor attention due to its robust growth potential and an impressive..

Omnicell, Inc. (OMCL) Stock Analysis: Potential 39% Upside Amidst Solid Growth in Healthcare Solutions

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, stands out not just for its innovative solutions in medication management and adherence but also..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: 52% Potential Upside Sparks Interest

Investors are increasingly turning their attention to Scholar Rock Holding Corporation (SRRK), as a staggering 52.24% potential upside is catching the eye of those looking for..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 51% Upside Potential in the Innovative Genomics Sector

Twist Bioscience Corporation (NASDAQ: TWST), a key player in the rapidly evolving field of synthetic biology and genomics, presents an intriguing investment opportunity, particularly for those..

Metsera, Inc. (MTSR) Stock Analysis: A Potential 32.51% Upside in the Booming Biotech Sector

Metsera, Inc. (NASDAQ: MTSR), a burgeoning name in the biotechnology sphere, is captivating investor attention with its groundbreaking approach to tackling obesity and related metabolic disorders...

SS Innovations International (SSII) Stock Analysis: A Closer Look at Its 121.80% Revenue Growth Amidst a Challenging Market

SS Innovations International, Inc. (SSII), a pioneering force in the surgical robotics sector, has garnered significant attention with its staggering 121.80% revenue growth. As a commercial-stage..

Phreesia, Inc. (PHR) Stock Analysis: A 37% Potential Upside Amid Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based software and payment platform, serving a diverse clientele across the United..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds